Everything below concerns nuclear receptor. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-12-03. Numbers and descriptions here follow the published literature rather than marketing material.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| Molecular weight | 437.9 g/mol | Calculated from the formula |
| Primary target | REV-ERBα and REV-ERBβ | Nuclear receptors involved in circadian regulation |
| Solubility | Soluble in DMSO and ethanol | Poorly soluble in water |
| Typical storage | -20 °C, desiccated | Protect from light and moisture |
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
The closure temperature or blocking temperature represents the temperature below which the mineral is a closed system for the studied isotopes. If a material that selectively rejects the daughter nuclide is heated above this temperature, any daughter nuclides that have been accumulated over time will be lost through diffusion, resetting the isotopic "clock" to zero. As the mineral cools, the crystal structure begins to form and diffusion of isotopes is less easy. At a certain temperature, the crystal structure has formed sufficiently to prevent diffusion of isotopes. Thus an igneous or metamorphic rock or melt, which is slowly cooling, does not begin to exhibit measurable radioactive decay until it cools below the closure temperature. The age that can be calculated by radiometric dating is thus the time at which the rock or mineral cooled to closure temperature. This temperature varies for every mineral and isotopic system, so a system can be closed for one mineral but open for another. Dating of different minerals and/or isotope systems (with differing closure temperatures) within the same rock can therefore enable the tracking of the thermal history of the rock in question with time, and thus the history of metamorphic events may become known in detail. These temperatures are experimentally determined in the lab by artificially resetting sample minerals using a high-temperature furnace. This field is known as thermochronology or thermochronometry.
Each lactoferrin molecule can reversibly bind two ions of iron, zinc, copper or other metals. The binding sites are localized in each of the two protein globules. There, each ion is bonded with six ligands: four from the polypeptide chain (two tyrosine residues, one histidine residue and one aspartic acid residue) and two from carbonate or bicarbonate ions. Lactoferrin forms a reddish complex with iron; its affinity for iron is 300 times higher than that of transferrin. The affinity increases in weakly acidic medium. This facilitates the transfer of iron from transferrin to lactoferrin during inflammations, when the pH of tissues decreases due to accumulation of lactic and other acids. The saturated iron concentration in lactoferrin in human milk is estimated as 10 to 30% (100% corresponds to all lactoferrin molecules containing 2 iron atoms). It is demonstrated that lactoferrin is involved not only in the transport of iron, zinc and copper, but also in the regulation of their intake. Presence of loose ions of zinc and copper does not affect the iron binding ability of lactoferrin, and might even increase it.
=== Specificity === The specific activities of sv-LAAOs with various L-amino acids have been explored. Many studies show that a number of sv-LAAOs exhibit a preference for hydrophobic L-amino acids as substrates. For example, results have indicated that most sv-LAAOs demonstrate relatively high specificities toward hydrophobic amino acids such as L-Met, L-Leu, and L-Ile in addition to aromatic amino acids such as L-Phe and L-Trp.
[HbH]+ + O2 ⇌ HbO2 + H+ as this shows that when hydrogen ion concentration increases the equilibrium is shifted to the left in accordance with Le Châtelier's principle. Hydrogen ion concentration can be increased by the presence of carbon dioxide, which behaves as a weak acid.
Most reptiles are insectivorous or carnivorous and have simple and comparatively short digestive tracts due to meat being fairly simple to break down and digest. Digestion is slower than in mammals, reflecting their lower resting metabolism and their inability to divide and masticate their food. Their poikilotherm metabolism has very low energy requirements, allowing large reptiles like crocodiles and large constrictors to live from a single large meal for months, digesting it slowly. While modern reptiles are predominantly carnivorous, during the early history of reptiles several groups produced some herbivorous megafauna: in the Paleozoic, the pareiasaurs; and in the Mesozoic several lines of dinosaurs. Today, turtles are the only predominantly herbivorous reptile group, but several lines of agamas and iguanas have evolved to live wholly or partly on plants. Herbivorous reptiles face the same problems of mastication as herbivorous mammals but, lacking the complex teeth of mammals, many species swallow rocks and pebbles (so called gastroliths) to aid in digestion: The rocks are washed around in the stomach, helping to grind up plant matter. Fossil gastroliths have been found associated with both ornithopods and sauropods, though whether they actually functioned as a gastric mill in the latter is disputed. Salt water crocodiles also use gastroliths as ballast, stabilizing them in the water or helping them to dive. A dual function as both stabilizing ballast and digestion aid has been suggested for gastroliths found in plesiosaurs.
Sources: en.wikipedia.org
== Trial and imprisonment == Allitt had attacked 13 children, four fatally, over a 59-day period. It was only following the death of Becky Phillips that medical staff became suspicious of the number of cardiac arrests on the children's ward and police were called in. It was found that Allitt was the only nurse on duty for all the attacks on the children and had access to the drugs used. Four of Allitt's victims had died. She was charged with four counts of murder, eleven counts of attempted murder, and eleven counts of causing grievous bodily harm. Allitt entered pleas of not guilty to all charges. On 28 May 1993, she was found guilty on each charge and sentenced to 13 concurrent terms of life imprisonment, which she is serving at Rampton Secure Hospital in Nottinghamshire. On 6 December 2007, Mr Justice Stanley Burnton, sitting in the High Court of Justice, London, ordered Allitt to serve the original minimum sentence of 30 years. It was reported that some families of Allitt's victims had previously mistakenly believed that her minimum tariff had been set at 40 years. Her minimum tariff expired in November 2021 and she is now eligible for release on parole. Allitt's motives have never been fully explained. According to one theory, she showed symptoms of a factitious disorder also known as Munchausen syndrome by proxy. On 3 October 2023, it was reported that Allitt was appearing before a mental health tribunal to be assessed for a potential transfer to a mainstream prison. If the transfer takes place, Allitt will be eligible for parole after six months.
The most recent estimate of reserve base for zinc (meets specified minimum physical criteria related to current mining and production practices) was made in 2009 and was calculated to be roughly 480 Mt. Zinc reserves, on the other hand, are geologically identified ore bodies whose suitability for recovery is economically practical (based on variables such as location, grade, quality, and quantity) at the time of determination. Since exploration and mine development is an ongoing process, the amount and number of zinc reserves is not a fixed number, and sustainability of zinc ore supplies cannot be judged by simply extrapolating the combined mine life of today's zinc mines. This concept is well supported by data from the United States Geological Survey (USGS), which illustrates that although refined zinc production increased 80% between 1990 and 2010, the reserve lifetime for zinc has remained unchanged, through the discovery of additional zinc deposits. About 346 million tonnes have been extracted throughout history up to 2002, and scholars have estimated that about 109–305 million tonnes are presently in use.
Meanwhile, the Central and Eastern European communist states politically deteriorated in response to the success of the Polish Solidarity movement and the possibility of Gorbachev-style political liberalisation. In 1989, revolts began across Central and Eastern Europe and China against Marxist–Leninist regimes. In China, the government refused to negotiate with student protestors, resulting in the 1989 Tiananmen Square massacre that stopped the revolts by force. The Pan-European Picnic, which was based on an idea by Otto von Habsburg to test the reaction of the Soviet Union, then triggered a peaceful chain reaction in August 1989, at the end of which there was no longer East Germany and the Iron Curtain and the Marxist–Leninist Eastern Bloc had collapsed. On the one hand, as a result of the Pan-European Picnic, the Marxist–Leninist rulers of the Eastern Bloc did not act decisively, but cracks appeared between them and on the other hand the media-informed Central and Eastern European population now noticed a steady loss of power in their governments.
== Pathology == In males, inadequate embryonal AMH activity can lead to persistent Müllerian duct syndrome (PMDS), in which a rudimentary uterus is present and testes are usually undescended. The AMH gene (AMH) or the gene for its receptor (AMH-RII) are usually abnormal. AMH measurements have also become widely used in the evaluation of testicular presence and function in infants with intersex variations, ambiguous genitalia, and cryptorchidism. Female offspring of pregnant mice injected with AMH develop polyendocrine metabolic ovarian syndrome (PMOS)-like symptoms, including infertility, delayed puberty, and erratic ovulation. Injection of GnRH antagonist cetrorelix prevents the appearance of reproductive defects in this context. This implies excess of AMH may cause PMOS through GnRH signaling.
Most bark is collected illegally by local people who are paid 150 CFA francs per kilo (about US$0.10 per pound) for delivery of pre-dried bark at the roadside. In practice they confuse and mix it with P. macroceras ("false yohimbe"), a species that contains little yohimbine.
Sources: en.wikipedia.org
It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.
It binds to REV-ERBα and REV-ERBβ, nuclear receptors involved in circadian and metabolic gene regulation. This can alter transcription of genes related to lipid and glucose metabolism in experimental models.
No controlled human trials have established that effect. Endurance findings come primarily from rodent studies, and human responses remain unknown.
SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.